Expression of the B cell-associated transcription factors PAX5, OCT-2, and BOB.1 in acute myeloid leukemia: Associations with B-Cell antigen expression and myelomonocytic maturation

American Journal of Clinical Pathology

Volumn 126, Issue 6, 2006, Pages 916-924

  Gibson, Sarah E ^a   Dong, Henry Y ^a   Advani, Anjali S ^b   Hsi, Eric D ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b Genzyme Genetics   (United States)

Author keywords

Acute myeloid leukemia; AML; BOB.1; OCT 2; PAX5

Indexed keywords

B LYMPHOCYTE ANTIGEN; OCTAMER TRANSCRIPTION FACTOR 2; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR BOB 1; TRANSCRIPTION FACTOR PAX5;

ACUTE GRANULOCYTIC LEUKEMIA; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; BONE MARROW; BONE MARROW CELL; CANCER DIAGNOSIS; CELL MATURATION; CHROMOSOME TRANSLOCATION 8; CONTROLLED STUDY; DISEASE ASSOCIATION; HEMATOPOIESIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MONOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

EID: 33845445651     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/UJUL60UPUP3YJE93     Document Type: Article

References (55)

1. Adams B, Dorfler P, Aguzzi A, et al. Pax-5 encode the transcription factor BSAP and is expressed in B-lymphocytes, the developing CNS, and adult testis. Genes Dev. 1992;6:1589-1607.
2. Nutt SL, Heavey B, Rolink AG, et al. Commitment to the B-lymphoid lineage depends on the transcription factor Pax5. Nature. 1999;401:556-562.
3. Horcher M, Souabni A, Busslinger M. Pax5/BSAP maintains the identity of B cells in late B lymphopoiesis. Immunity. 2001;14:779-790.
4. Li YS, Wasserman R, Hayakawa K, et al. Identification of the earliest B lineage stage in mouse bone marrow. Immunity. 1996;5:527-535.
5. Kerhl JH, Riva A, Wilson GL, et al. Molecular mechanisms regulating CD19, CD20 and CD22 gene expression. Immunol Today. 1994;15:432-436.
6. Kozmik Z, Wang S, Dorfler P, et al. The promoter of the CD19 gene is a target for the B-cell-specific transcription factor BSAP. Mol Cell Biol. 1992;12:2662-2672.
7. Nutt SL, Morrison AM, Dorfler P, et al. Identification of BSAP (Pax-5) target genes in early B-cell development by loss- and gain-of-function experiments. EMBO J. 1998;15:2319-2333.
8. Zwollo P, Arrieta H, Ede K, et al. The Pax-5 gene is alternatively spliced during B-cell development. J Biol Chem. 1997;272:10160-10168.
9. Schebesta M, Heavey B, Busslinger M. Transcriptional control of B-cell development. Curr Opin Immunol. 2002;14:216-223.
10. Souabni A, Cobaleda C, Schebesta M, et al. Pax5 promotes B lymphopoiesis and blocks T cell development by repressing Notch 1. Immunity. 2002;17:781-793.
11. Busslinger M, Urbanek P. The role of BSAP (Pax-5) in B-cell development. Curr Opin Genet Dev. 1995;5:595-601.
12. Max EE, Wakatsuki Y, Neurath MF, et al. The role of BSAP in immunoglobulin isotype switching and B-cell proliferation. Curr Top Microbiol Immunol. 1995;194:449-458.
13. Iiada S, Rao PH, Nallasivam P, et al. The t(9;14)(p13;q32) chromosomal translocation associated with lymphoplasmacytoid lymphoma involves the PAX-5 gene. Blood. 1996;88:4110-4117.
14. Hannada T, Yonetani N, Ueda C, et al. Expression of the PAX5/BSAP transcription factor in haematological tumour cells and further molecular characterization of the t(9;14)(p13;q32) translocation in B-cell non-Hodgkin's lymphoma. Br J Haematol. 1998;102:691-700.
15. Morrison AM, Jager U, Chott A, et al. Deregulated PAX-5 transcription from a translocated IgH promoter in marginal zone lymphoma. Blood. 1998;92:3865-3878.
16. Pasqualucci L, Neumeister P, Goossens T, et al. Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas. Nature. 2001;412:341-346.
17. Krenacs L, Himmelmann AW, Quintanilla-Martinez L, et al. Transcription factor B-cell-specific activator protein (BSAP) is differentially expressed in B cells and subsets of B-cell lymphomas. Blood. 1998;92:1308-1316.
18. Torlakovic E, Torlakovic G, Nguyen PL, et al. The value of anti-Pax-5 immunostaining in routinely fixed and paraffin-embedded sections: a novel pan pre-B and B-cell marker. Am J Surg Pathol. 2002;26:1343-1350.
19. Foss H, Reusch R, Demel G, et al. Frequent expression of the B-cell-specific activator protein in Reed-Sternberg cells of classical Hodgkin's disease provides further evidence of its B-cell origin. Blood. 1999;94:3108-3113.
20. Hertel CB, Zhou X, Hamilton-Dutoit SJ, et al. Loss of B cell identity correlates with loss of B cell-specific transcription factors in Hodgkin/Reed-Sternberg cells of classical Hodgkin lymphoma. Oncogene. 2002;21:4908-4920.
21. Tiacci E, Pileri S, Orleth A, et al. PAX5 expression in acute leukemias: higher B-lineage specificity than CD79a and selective association with t(8;21)-acute myelogenous leukemia. Cancer Res. 2004;64:7399-7404.
22. Dong HY. Activation of CD19 in acute myeloid leukemia and T-cell lymphoma/leukemia is correlated with expression of its upstream transcriptional activator PAX5 [abstract]. Mod Pathol. 2005;18:228A.
23. Latchman DS. The Oct-2 transcription factor. Int J Biochem Cell Biol. 1996;28:1081-1083.
24. Shah PC, Bertolino E, Singh H, et al. Using altered specificity Oct-1 and Oct-2 mutants to analyze the regulation of immunoglobulin gene transcriprion. EMBO J. 1997;16:7105-7117.
25. Luo Y, Roeder RG. Cloning, functional characterization, and mechanisms of action of the B-cell-specific transcriptional coactivator OCA-B. Mol Cell Biol. 1995;15:4115-4124.
26. Chang JF, Phillips K, Lundback T, et al. Oct.-1 POU and octamer DNA co-operate to recognise the Bob-1 transcription co-activator via induced folding. J Mol Biol. 1999;21:941-952.
27. Qin XF, Reichlin A, Luo Y, et al. OCA-B integrates B cell antigen receptor-, CD40L-, and IL-4-mediated signals for the germinal center pathway of B cell development. EMBO J. 1998;17:5066-5075.
28. Greiner A, Muller KB, Hess J, et al. Up-regulation of BOB.1/OBF.1 expression in normal germinal center B cells and germinal center-derived lymphomas. Am J Pathol. 2000;156:501-507.
29. Hess J, Nielsen PJ, Fischer KD, et al. The B lymphocyte-specific coactivator BOB.1/OBF.1 is required at multiple stages of B-cell development. Mol Cell Biol. 2001;21:1531-1539.
30. Stein H, Marafioti T, Foss HD, et al. Down-regulation of BOB.1/OBF.1 and Oct-2 in classical Hodgkin disease but not in lymphocyte predominant Hodgkin disease correlates with immunoglobulin transcription. Blood. 2001;97:496-501.
31. Saez AI, Artiga MJ, Sanchez-Beato M, et al. Analysis of octamer-binding transcription factors Oct2 and Oct1 and their coactivaror BOB.1/OBF.1 in lymphomas. Mod Pathol. 2002;15:211-220.
32. Pileri SA, Gaidano G, Zinzani PL, et al. Primary mediastinal B-cell lymphoma: high frequency of bcl-6 mutations and consistent expression of the transcription factors OCT-2, BOB.1, and PU.1 in the absence of immunoglobulins. Am J Pathol. 2003;162:243-253.
33. Marafiori T, Ascani S, Pulford K, et al. Expression of B-lymphocyte-associated transcription factors in human T-cell neoplasms. Am J Pathol. 2003;162:861-871.
34. Libermann TA, Zheng P, Akbarali Y, et al. AML1 (CBFα2) cooperates with B cell-specific activating protein (BSAP/PAX5) in activation of the B cell-specific BLK gene promoter. J Biol Chem. 1999;274:24671-24676.
35. Zhao F, Vilardi A, Neely RJ, et al. Promotion of cell cycle-progression by basic helix-loop-helix E2A. Mol Cell Biol. 2001;21:6346-6357.
36. Mueller BU, Pabst T, Fos J, et al. ATRA resolves the differentiation block in t(15;17) acute myeloid leukemia by restoring PU.1 expression. Blood. 2006;107:3330-3338.
37. Arber DA, Jenkins KA. Paraffin section immunophenotyping of acute leukemias in bone marrow specimens. Am J Clin Pathol. 1996;106:462-468.
38. Zimpfer A, Schonberg S, Lugli A, et al. Construction and validation of a bone marrow tissue microarray. J Clin Pathol. 2006. Available at http://jcp.bmjjournals.com/cgi/rapidpdf/jcp.2005.035758v1. Accessed June 20, 2006.
39. Dunn TL, Ross IL, Hume DA. Transcription factor Oct-2 is expressed in primary murine macrophages [letter]. Blood. 1996;88:4072.
40. Lopez-Rodriguez C, Zubiaur M, Sancho J, et al. An octamer element functions as a regulatory element in the differentiation-responsive CD11c integrin gene promoter: Oct-2 inducibility during myelomonocytic differentiation. J Immunol. 1997;158:5833-5840.
41. Neumann M, Fries HW, Scheicher C, et al. Differential expression of Rel/NF-κB and octamer factors is a hallmark of the generation and maturation of dendritic cells. Blood. 2000;95:277-285.
42. Neumann D, Strasser A, Wesche H, et al. Overexpression of the bcl-2 oncogene in the mouse pre-B cell line SPGM-1 protects from apoptosis, but does not affect blocked B-lineage differentiation and lineage switch towards macrophage like cells. Cell Death Differ. 1997;4:580-589.
43. Martin M, Strasser A, Baumgarth N, et al. A novel cellular model (SPGM1) of switching between the pro-B cell and myelomonocytic lineages. J Immnnol. 1993;150:4395-4406.
44. Spencker T, Neumann D, Strasser A, et al. Lineage switch of a mouse pre-B cell line (SPGM-1) to macrophagc-like cells after incubation with phorbol ester and calcium ionophore. Biochem Biophys Res Commun. 1995;216:540-548.
45. Borzillo GV, Ashmun RA, Sherr CJ. Macrophage lineage switching of murine early pre-B lymphoid cells expressing transduced fins genes. Mol Cell Biol. 1990;10:2703-2714.
46. Bauer SR, Holmes KL, Morse HC, et al. Clonal relationship of the lymphoblastic cell line P388 to the macrophage cell line P388D1 as evidenced by immunoglobulin gene rearrangements and expression of cell surface antigens. J Immunol. 1986;136:4695-4699.
47. Klinken SP, Alexander WS, Adams JM. Hematopoietic lineage switch: v-raf oncogene converts Eμ-myc transgenic B cells into macrophages. Cell. 1988;53:857-867.
48. Boyd AW, Schrader JW. Derivation of macrophage-like lines from the pre-B lymphoma ABLS 8.1 using 5-azacytidine. Nature. 1982;297:691-693.
49. Davidson WF, Pierce JH, Rudikoff S, et al. Relationships between B cell and myeloid differentiation: studies with a B lymphocyte progenitor line, HAFTL-1. J Exp Med. 1988;168:389-407.
50. Xie H, Ye M, Feng R, et al. Stepwise reprogramming of B cells into macrophages. Cell. 2004;117:663-676.
51. Kee BL, Murre C. Induction of early B cell factor (EBF) and multiple B lineage genes by the basic helix-loop-helix transcription factor E12. J Exp Med. 1998;188:699-713.
52. Montecino-Rodriguez E, Leathers H, Dorshkind K. Bipotential B-macrophage progenitors are present in adult bone marrow. Nat Immunol. 2001;2:83-88.
53. Katsura Y. Redefinition of lymphoid progenitors. Nat Rev Immunol. 2002;2:1-6.
54. Chen H, Zhang P, Radomska HS, et al. Octamer binding factors and their coactivator can activate the murine PU.1 (spi-1) promoter. J Biol Chem. 1996;271:15743-15752.
55. Hegde PS, White IR, Debouck C. Interplay of transcriptomics and proteomics. Curr Opin Biotechnol. 2003;14:647-651.